Abstract
IT has been shown in this laboratory that under some experimental conditions the homologous bone marrow treatment may be successful in preventing fatal bone marrow aplasia induced by high doses of ‘Myleran’1,2. On the other hand, it is well known that a number of lethally whole-body irradiated mammals, which survive the first 30 days after exposure, thanks to homologous or heterologous bone marrow transfusions, may succumb during the second and third month3,4. This delayed mortality known as secondary disease is attributed by several investigators to an immunological reaction of the graft versus the host. Some success has been reported in preventing or treating the secondary disease in irradiated animals by various means5–10. In this communication the preliminary results concerning absence of secondary disease in rats treated with homologous bone marrow transfusions after administration of ‘Myleran’ are given.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Dunjic, A., Verh. kon. Acad. Geneesk. Belg., 24, 343 (1962).
Dunjic, A., Nature, 194, 493 (1962).
Congdon, C. C., Progress in Hematology, 2, 21 (Pergamon Press, London, 1959).
Van Bekkum, D. W., Mechanisms in Radiobiology, 2, 297 (Academic Press, New York, 1960).
Barnes, D. W. H., Ilbery, P. L. T., and Loutit, J. F., Nature, 181, 488 (1958).
Uphoff, D. E., J. Nat. Cancer Inst., 20, 625 (1958).
Cudkowicz, G., Proc. Soc. Exp. Biol., 107, 821 (1961).
Uphoff, D. E., Proc. Soc. Exp. Biol., 99, 651, (1958).
Cudkowicz, G., and Cosgrove, G. E., Transpl. Bull., 27, 90 (1961).
Van Bekkum, D. W., and Vos, O., Intern. J. Rad. Biol., 3, 173 (1962).
Maisin, H., thesis, Arcia, Bruxelles (1959).
Dunjic, A. (in preparation).
Congdon, C. C., and Urso, I. S., Amer. J. Path., 33, 749 (1957).
Elson, L. A., Galton, D. A. G., and Till, M., Brit. J. Hœmatol., 4, 355 (1958).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
DUNJIC, A. Absence of Secondary Disease in Rats treated with Homologous Bone Marrow Transfusions after Administration of ‘Myleran’. Nature 198, 603–604 (1963). https://doi.org/10.1038/198603b0
Issue Date:
DOI: https://doi.org/10.1038/198603b0
This article is cited by
-
Zur Frage eines geeigneten Zeitabstandes zwischen der Letal-Bestrahlung von Mäusen und Transplantation von Knochenmark
Blut Zeitschrift für die Gesamte Blutforschung (1972)
-
Bone-marrow Transplantation after Antilymphocytic Serum and Lethal Chemotherapy
Nature (1969)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
